Glenmark Life Sciences Cash Flow Annual

Trade
BSE: 543322 | NSE: GLS | ISIN: INE03Q201024 | Sector: Biotechnology & Drugs
1,097.55 +48.65 (4.64%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 631.29628.61564.93470.94
Depreciation/ Depletion 53.4542.0937.8833.39
Non- Cash Items 37.848.9939.89100.35
Changesin Working Capital -309.06-366.29-45.11-216.57
Cashfrom Operating Activities 413.52313.40597.59388.11
Capital Expenditures -128.97-170.20-132.17-67.99
Other Investing Cash Flow Items Total 12.4916.059.94-0.74
Cashfrom Investing Activities -116.48-154.15-122.23-68.73
Financing Cash Flow Items -1.55-0.03-0.07-
Total Cash Dividends Paid -275.69-385.92-128.65-
Issuance( Retirement)of Debt Net -2.21-1.64-961.92-213.78
Cashfrom Financing Activities -279.44-387.59-78.80-213.78
Net Changein Cash 17.59-228.33396.56105.60
Cash Interest Paid 1.550.030.07-
Cash Taxes Paid 162.96153.57138.17108.56
Issuance( Retirement)of Stock Net -0.001,011.850.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts